Covered recipient · General Payments record
GREGORY M ORLOWSKI
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2024–2025
$609.64
- Reported across 17 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $496.62 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Scientific Affairs, LLC | $144.21 | 1 |
| ABBVIE INC. | $90.86 | 3 |
| UCB, Inc. | $63.24 | 3 |
| Arcutis Biotherapeutics, Inc. | $41.73 | 2 |
| Amgen Inc. | $31.22 | 1 |
| GENZYME CORPORATION | $26.95 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.04 | 1 |
| Organon LLC | $25.75 | 1 |
| Galderma Laboratories, L.P. | $23.89 | 1 |
| Regeneron Healthcare Solutions, Inc. | $15.23 | 1 |
| Janssen Biotech, Inc. | $7.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.42 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203396953 | CMS |
| ABBVIE INC. | $28.99 | 12/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203396961 | CMS |
| ABBVIE INC. | $32.45 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203396967 | CMS |
| Amgen Inc. | $31.22 | 11/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228465081 | CMS |
| Arcutis Biotherapeutics, Inc. | $23.85 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1252344005 | CMS |
| Arcutis Biotherapeutics, Inc. | $17.88 | 12/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1252344007 | CMS |
| Galderma Laboratories, L.P. | $23.89 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234686616 | CMS |
| GENZYME CORPORATION | $26.95 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233627474 | CMS |
| Janssen Biotech, Inc. | $7.50 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174663428 | CMS |
| Janssen Scientific Affairs, LLC | $144.21 | 03/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174170618 | CMS |
| Novartis Pharmaceuticals Corporation | $26.04 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200656578 | CMS |
| Organon LLC | $25.75 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237696016 | CMS |
| Regeneron Healthcare Solutions, Inc. | $15.23 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1213003922 | CMS |
| UCB, Inc. | $27.39 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224389274 | CMS |
| UCB, Inc. | $17.12 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224389276 | CMS |
| UCB, Inc. | $18.73 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224389278 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.